Cyclopentolate Hydrochloride

盐酸环喷托酯

Report date: 2023/02/23 20:00:33
NME

Base Information

Drug NameCyclopentolate Hydrochloride
Drug Alias NameCyclopentolatum环喷托酯盐酸环喷托脂CyclopentolateCiclopentolato +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsCycloplegiaMydriasis
Global Approved IndicationsCycloplegiaMydriasis
Approved Indications in ChinaCycloplegiaMydriasis
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesBausch & Lomb U.K. LtdSantenShandong Bausch & Lamb Freda Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCycloplegiaMydriasis
Inactive IndicationsN/A

Other Information

ATC CodeS01FA04
Related LinksWikipediaDrugBankKEGG